
Analyst Ananda Ghosh of H.C. Wainwright maintained a Buy rating on Dyne Therapeutics, with a price target of $32.00. Ananda Ghosh gave his rating based on several factors, including the
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| DYN | Dyne Therapeutics | 15.50 | -3.95 | -20.33% |
| Name | Price | % Change | |
|---|---|---|---|
| $15.50 | -20.33% |

Analyst Ananda Ghosh of H.C. Wainwright maintained a Buy rating on Dyne Therapeutics, with a price target of $32.00. Ananda Ghosh gave his rating based on several factors, including the

Reports Q3 research and development expenses $161.7M vs. $97.2M last year. Reports Q3 general and administrative expenses $35.3M vs. $16.7M last year. Reports cash, cash equivalents and marketable securities $1.134B

As previously reported, Oppenheimer downgraded Dyne Therapeutics (DYN) to Perform from Outperform with a price target of $15, down from $40. Although the firm views Dyne’s DM1 therapy as superior

Oppenheimer downgraded Dyne Therapeutics (DYN) to Perform from Outperform with a price target of $15, down from $40. Published first on TheFly – the ultimate source for real-time, market-moving breaking

Analyst Francois Brisebois of LifeSci Capital reiterated a Buy rating on Dyne Therapeutics, retaining the price target of $40.00. Francois Brisebois has given his Buy rating due to a combination

H.C. Wainwright lowered the firm’s price target on Dyne Therapeutics (DYN) to $32 from $50 and keeps a Buy rating on the shares. The company’s update yesterday update supports the

The latest update is out from Dyne Therapeutics ( ($DYN) ). On September 29, 2026, Dyne Therapeutics reported additional one-year clinical data from the multiple ascending dose portion of its

Piper Sandler is confident Dyne Therapeutics’ (DYN) Zeleciment rostudirsen will gain accelerated approval in Duchenne muscular dystrophy boys amenable to exon 51 skipping by the January 21st PDUFA date with

Meeting to be held on October 5-8 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders’ Hot

What has Wall Street been buzzing about this week? Here are the top 5 Buy calls and the top 5 Sell calls made by Wall Street’s best analysts during the
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| buy | Reiterated | Nov 11, 2026 | ||||
| buy | Reiterated | Nov 6, 2026 | ||||
| buy | Assigned | Nov 6, 2026 | ||||
| buy | Reiterated | Nov 5, 2026 | ||||
| hold | Downgraded | Oct 28, 2026 | ||||
| buy | Reiterated | Sep 30, 2026 | ||||
| buy | Reiterated | Sep 30, 2026 | ||||
| buy | Reiterated | Sep 29, 2026 | ||||
| buy | Reiterated | Sep 9, 2026 | ||||
| buy | Reiterated | Sep 8, 2026 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Mar 4, 2027TBA | $3.00B | $-1.00 | $0.00 | -1.90 | -4.42 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.